Medicare Advantage contract
H0351 Wellcare by Allwell
Local CCP · Parent: Centene Corporation
⚠ Non-renewal
Latest enrollment
20,163
2025-01
Year-over-year
+18.4%
contract book
National MA share
+0.0%
rank #263 of 936
Overall stars (latest)
★★★ 3.0
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2020 | ★★★ 3.0 | 2.5 | 3.0 | — |
| 2021 | ★★★ 3.0 | 3.0 | 3.0 | — |
| 2022 | ★★★ 3.0 | 3.0 | 3.5 | — |
| 2023 | ★★½ 2.5 | 2.5 | 3.0 | -0.5 |
| 2024 | ★★★ 3.0 | 3.0 | 3.5 | +0.5 |
Premium
Median monthly plan premium across this contract's plans, by year.
| Plan | Year | Monthly premium | Part D premium |
|---|---|---|---|
| H0351-038 | 2026 | $0.00 | $0.00 |
| H0351-053 | 2026 | $0.00 | $0.00 |
| H0351-054 | 2026 | $0.00 | $0.00 |
| H0351-057 | 2026 | $0.00 | $0.00 |
| H0351-063 | 2026 | $0.00 | $0.00 |
| H0351-064 | 2026 | $0.00 | $0.00 |
| H0351-065 | 2026 | $0.00 | $0.00 |
| H0351-066 | 2026 | $9.50 | $9.50 |
| H0351-067 | 2026 | $0.00 | $0.00 |
| H0351-068 | 2026 | $9.50 | $9.50 |
| H0351-069 | 2026 | $0.00 | $0.00 |
| H0351-070 | 2026 | $0.00 | $0.00 |
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- C18 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions 1★ → 4★
- C25 Complaints about the Health Plan 1★ → 3★
- D11 MTM Program Completion Rate for CMR 5★ → 3★
- D03 Members Choosing to Leave the Plan 3★ → 5★
- C28 Plan Makes Timely Decisions about Appeals 3★ → 5★
- C26 Members Choosing to Leave the Plan 3★ → 5★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →